Tenax Therapeutics faces a class action lawsuit for allegedly misleading investors about the effectiveness of its drug levosimendan during clinical trials. The company claimed positive results from earlier studies, but its Phase 3 trial failed to meet key endpoints, causing the stock to drop nearly 90% in August 2026. Investors who bought Tenax shares between November 2023 and August 2026 may join the lawsuit, with a lead plaintiff deadline of December 28, 2026. The case highlights risks in investing in development-stage biotech firms with uncertain drug prospects.
Tenax Therapeutics faces a class action lawsuit, with Pluang's Health sector showing mixed performance. For readers following health stocks, here is Pluang's market snapshot as of Oct 28, 2026 09:41 WIB: out of 150 priced US health-sector stocks, 89 rose and 61 fell. Notable movers include TWST at USD 160.52 (+10.51%, 0% Sell / 100% Buy, typical hold time 27 days), MRVI at USD 8.21 (+8.38%, typical hold time 9 days), and SLS at USD 12.17 (+7.32%, typical hold time 6 days).
India's plastics industry is projected to grow from USD 49.98 billion in 2027 to USD 68.41 billion by 2032, at a CAGR of 6.48%. Growth is fueled by rising demand in packaging, pharmaceuticals, electric two-wheelers, and construction, alongside polyme...
Grupo Aeroportuario del Pacífico (GAP) announced a dividend payment of 20.80 pesos per share, approved at its April 2026 shareholders' meeting. The dividend will be paid on November 6, 2026, to shareholders presenting coupon No. 42 of their share cer...
As of October 25, Strategy maintained a holding of approximately 848,517 Bitcoin (BTC). There were no purchases or sales of Bitcoin by Strategy between October 19 and October 25. This stable position indicates a hold strategy during this period witho...
On October 27, Bitway (BTW) surged 34.97% to $1.54, topping the 24-hour performance among the 90 largest cryptocurrencies excluding stablecoins. Despite this gain, the broader market saw more declines than advances, with 55 cryptocurrencies falling a...
Vitalik Buterin, Ethereum co-founder, transferred $1 million in USDC stablecoin to the Kanro Fund, his biotech-focused philanthropy, without any public announcement. The transfer was identified through blockchain data on October 28, 2026, highlightin...
